Macbee Planet (7095) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Jul, 2025Executive summary
Achieved record-high sales with net sales rising 26.1% year-over-year to ¥11,560 million, driven by medical industry projects and LTV Marketing segment growth.
Operating profit increased 14.8% to ¥1,146 million, while profit attributable to owners of parent fell 23.7% to ¥533 million.
Launched "LP Pro" and expanded investor base; enhanced organizational structure with a new PR Strategy Division.
Changed listing to the Tokyo Stock Exchange Prime Market and made PR Cloud Tech a wholly owned subsidiary.
Focused on proprietary technology and LTV marketing amid a favorable digital advertising environment.
Financial highlights
Q1 FY04/2025 sales rose 26% year-over-year to ¥11,560 million; gross profit increased to ¥2,248 million, up 15.3% year-over-year.
EBITDA increased 18% year-over-year to ¥1,311 million; operating profit up 18% to ¥1,175 million.
Operating profit margin slightly decreased to 10.2% from 10.9% year-over-year; gross margin at 19.4%.
EPS was 36.79 yen, reflecting a 4-for-1 stock split effective June 1, 2024.
Net assets increased to ¥10,676 million, with an equity ratio of 52.5%.
Outlook and guidance
Medium-term plan targets ¥70 billion in sales and ¥7.5 billion in operating profit by FY04/2027, representing 78% and 104% growth from FY04/2024.
Full-year forecast maintained: net sales of ¥48,000 million (+21.8%), operating profit of ¥4,500–5,000 million (+22.6–36.2%), and profit attributable to owners of parent of ¥2,720–3,070 million (+19.1–34.5%).
Ongoing investments in PR and advertising, with up to ¥0.5 billion planned for PR initiatives in the current fiscal year.
Profit per share forecasted at 187.57–211.70 yen for FY04/2025.
Allowance for doubtful accounts is being actively managed, with small reversals expected in future quarters.
Latest events from Macbee Planet
- Revenue and profit fell sharply year-over-year, but full-year guidance is maintained.7095
Q3 202613 Mar 2026 - Operating profit and margin fell as revenue growth slowed, leading to a downward forecast revision.7095
Q2 202611 Dec 2025 - Q1 revenue up 11% year-over-year, but profit fell sharply on higher ad costs; recovery forecast.7095
Q1 202611 Sep 2025 - Sales and profits more than doubled, with strong outlook and a 4-for-1 stock split ahead.7095
Q4 202424 Jul 2025 - Sales up 30% in 1H, with strong growth in medical, finance, and LTV Marketing.7095
Q2 202524 Jul 2025 - Net sales and profits rose sharply, with upgraded guidance and strong LTV Marketing growth.7095
Q3 202524 Jul 2025 - Record sales and profit growth, with strong FY2026 outlook and expanded shareholder returns.7095
Q4 202524 Jul 2025